MedCity News December 2, 2022
Marissa Plescia

Lumen sells a handheld device that measures users’ metabolism through breath and connects to an app that helps track goals and provides nutrition coaching. The funding round was led by Pitango Venture Capital, and included participation from Hanwha Group and Resolute Ventures.

Wellness and fitness company Lumen announced Thursday that it aims to bring its metabolism tracking platform to more consumers in the U.S. and globally after raking in $62 million in Series B funding.

The Tel Aviv, Israel-based startup was founded in 2014 by twin sisters Michal and Merav Mor when they were training for the Ironman, a triathlon consisting of swimming, biking and running. They created a peer-reviewed handheld device that measures users’ metabolism through breath and connects...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Apps, Digital Health, Investments, Medical Devices, Technology, Trends
Related Articles:
Tariffs and medical devices: What has the industry response been?
Tariffs and medical devices: Who ultimately pays for the tariffs?
Tariffs and medical devices: The effect on the supply chain
Tariffs and medical devices: Will factories move back to the US?
Tariffs and medical devices: How will they affect the industry?

Share This Article